Brain Imaging for Speech Learning
Trial Summary
Will I have to stop taking my current medications?
The trial excludes participants who are taking psychoactive medications, so you may need to stop taking those if you are currently on them. The protocol does not specify about other types of medications.
What data supports the effectiveness of the treatment Adaptation for speech learning?
Is the brain imaging treatment for speech learning safe for humans?
How does the Adaptation treatment for speech learning differ from other treatments?
The Adaptation treatment for speech learning is unique because it focuses on altering somatosensory inputs to enhance speech motor learning, which involves changes in brain connectivity between auditory and somatosensory areas. This approach is different from other treatments that may not specifically target these neural pathways or use robotic devices to modify sensory feedback.38101112
What is the purpose of this trial?
The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well. The strategy for the proposed research is to identify individual brain areas that contribute causally to retention by disrupting their activity with transcranial magnetic stimulation (TMS). Investigators will also use functional magnetic resonance imaging (fMRI) which will enable identification of circuit-level activity which predicts either learning or retention of new movements, and hence test the specific contributions of candidate sensory and motor zones. In other studies, investigators will record sensory and motor evoked potentials over the course of learning to determine the temporal order in which individual sensory and cortical motor regions contribute. The goal here is to identify brain areas in which learning-related plasticity occurs first and which among these areas predict subsequent learning.
Research Team
David Ostry
Principal Investigator
Yale University
Eligibility Criteria
This trial is for individuals who are interested in participating in research about speech. There are specific criteria to join, but they aren't listed here.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Speech Motor Learning
Participants perform learning tasks with altered auditory feedback and undergo fMRI. This session lasts 30 minutes.
Retention Assessment
Participants return 24 hours later to assess retention of learning using fMRI and other measures.
Follow-up
Participants are monitored for safety and effectiveness after the main trial activities
Treatment Details
Interventions
- Adaptation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Yale University
Lead Sponsor
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborator